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ABSTRACT- 
Gongronema latifolium (Asclepiadiaceae) is used as bitterspice or flavouring agent in many 
traditional Nigerian dishes. It is well known for medicinal and nutritional purposes like anti-
hyperglycemic, anti-oxidant, antitussive and widely distributed in the southeastern states of 
Nigeria. Objective of present study was to evaluate the anti-hyperglycemic and anti-oxidant 
effect of the methanol extract of Gongronema latifolium leaves. 
The methanol extract of G. latifolium at doses of 250 and 500 mg/kg were studied for anti-
hyperglycemic effect in alloxan-induced hyperglycemic rats. The variation in blood glucose level 
in normal and experimental rats on 0, 7, 14 and 21 days of treatment has also been recorded. 
Treatment with G. latifolium extract showed signs of recovery as comparable with the standard 
drug glibenclamide (0.25 mg/kg). The effect of different treatment on body weight of rats was 
also determined. 
The antioxidant properties of the extracts as determined by the DPPH free radical scavenging assay. The 
result showed that G. latifolium extract caused a concentration dependent percentage increase of 
antioxidant activity. 
Study concludes that methanol leaf extract of G. latifolium possessessignificant anti-
hyperglycemic and anti-oxidant activities. 
Keywords: Gongronema latifolium, anti-hyperglycemic, anti-oxidant, carrageenan-induced paw 
edema. 
 
INTRODUCTION 
Plants are extremely an important source of medicinal agents. Sinceancient times, plants have 
been used due to their impactful pharmacological properties. WHO estimates that 80% of the 
population living in rural areas is dependent on herbal medicine for their health needs. Crude plant 
extracts in the form of infusion, decoction, tincture or herbal extracts have been traditionally used by 
the population for the treatment of various diseases1. Plant used in treatment of diseases is as old as 
civilization and traditional medicines are still a major part of habitual treatments of different 
maladies
2
.  
Diabetes mellitus is the commonest endocrine disorder that affects more than 171 million people 
worldwide. It is a condition in which a person has a high blood sugar level. The reason may be 
either the body doesn’t produce enough insulin, or because body cells don’t properly respond to 
the insulin that is produced
3
. When the blood glucose increases for example, after eating food 
material, insulin is released from the pancreas to normalize the glucoselevel. If the body cells do 
not absorb glucose, the glucose accumulates in the blood, leading to vascular, neuron, and other 
complications
4
. 
Our body is exposed to a variety of oxidizing agents. Oxidation is a chemical reaction that 
produces free radicals, leading to chain reactions that may damage cells
5
. Body is equally inbuilt 
with antioxidants to cater for the free radicals generated from the oxidants, so a balance between 
the production of free radicals and neutralization by antioxidants is remains maintained. 
Antioxidants are substances known to protect the body from damagecaused by reactive oxygen 
 species induced oxidative stress6. Oxidative stress results because of imbalance between formation 
and neutralization of free radicals by antioxidants, it results to oxidative stress. Oxidative stress 
has been implicated in the etiology of diseases such as cardiovascular diseases and lung cancer. 
 Antioxidants from natural sources have a higher bioavailability and therefore higher protective 
efficacy comparison of synthetic antioxidants
7
. 
Gongronema latifolium (Asclepiadiaceae) is used for medicinal and nutritional purposes widely 
distributed in the southeastern states of Nigeria
8
. Apart from beingused as bitter spice or 
flavouring agent in many traditional Nigerian dishes  the plant leaves has been found very 
efficacious as an antidiarrhoeal and antitussive. Aerial parts are taken to treat cough, intestinal 
worms, dysentery, dyspepsia and malaria
9
. It is also taken as a tonic to treat loss of appetite. A 
decoction of leaves or leafy stems is commonly taken to treat diabetes and high blood pressure
10
. 
The objective of the present study was to evaluate the anti-hyperglycemic and anti-inflammatory 
properties of methanol leaf extract of Gongronema latifolium. 
MATERIAL AND METHODS 
Collection and preparation of leaf samples: 
Fresh leaves and roots of G. latifolium were collected from Niger Delta and authenticated.  
Extraction of plant materials 
Fresh leaves of G. latifolium were washed and allowed to dry air at roomtemperature (28 to 
30
o
C) for two weeks, to avoid the escape of volatile components by oven-drying. The dried 
leaves were milled into fine powder using the Christy-Norris hammer mill and passed through 
a1mm sieve to obtain a fine powder. 2 kg of the sample was percolated in methanol for 48 hrs; 
this was then filtered through a Whatman filter paper No.1. The filtrate was evaporated to 
dryness on a hot plate at an initial temperature of 100
0
C and the dry powder obtained was 
suspended in 10ml distilled water, stirred and refiltered
11
. 
Assessment of hypoglycaemic activity 
The approval of the Institutional Animal Ethics Committee was obtained before starting the 
study. An international protocol for conducting experiments on animals were followed. Healthy 
wistar rats of eithersex having weight 150 - 200 g were selected for this activity
12
. They were 
housed in standard condition of temperature (25 ± 2 
0
C) with 12 h light per day cycle. Before 
induction of diabetes weigh and normal glucose levels of rats were determined and recorded as 
Day 0.  The acclimatized animals were fasted for 24 h with water ad libitum
13
. 
Hyperglycemia was induced using a single intraperitoneal injection of alloxan monohydrate (160 
mg/kg).  
All animals were returned to their cages and given free access to food and water. Blood glucose 
levels were monitored by using a Glucometer after 72 h of injectionand recorded as 1st day.  
Rats with fasting blood glucose >7.8 mmol/l or 140 mg/dl were considered hyperglycemic and 
were selected for the study. 
Diabetic rats were randomly assigned to 5 groups, each group contains six animals.  
The animals were grouped as follow 
  Group I: Normal control 
  Group II: Diabetic control 
  Group III: Diabetic rats treated with G. latifolium extract (250 mg/kg) 
  Group IV: Diabetic rats treated with G. latifolium  extract (500 mg/kg) 
  Group V: Diabetic rats treated with glibenclamide (0.25 mg/kg). 
 Blood samples were obtained from the cut tail tip of the conscious rat and glucose test strip 
soaked with blood and then inserted to be read by the glucometer. Blood glucose levels were 
examined after 2, 12, 24, 72 hrs of orally administration of test drugs
14
. 
 
Table 1: The effect of different treatment on fasting blood glucose levels in alloxan induced 
diabetic rats 
 
Treatment 
Blood glucose level (mg/dl) 
0
th 
Day 7
th
 Day 14
th
 Day 21
st
 Day 
Normal control 90.4± 0.25 93.21± 0.26 92.47± 0.22 91.65± 0.15 
Diabetic control 247.58± 0.43 265.28± 0.31 280.37± 0.41 300.48± 0.42 
G. latifolium 
(250 mg/kg) 
245.72± 0.51 200.82± 0.42 150.47± 0.53 122.37± 0.37 
G. latifolium 
(500 mg/kg) 
247.38± 0.09 195.28± 0.51 142.37± 0.08 120.25± 0.22 
Glibenclamide 
(0.25 mg/kg) 
248.46± 0.13 179.23± 0.38 125.38± 0.06 112.37± 0.07 
      N = 6, p < 0.05 
Table 2: The effect of different treatment on body weight of  alloxan induced diabetic rats 
 
 
Treatment 
Change in body weight (gm) 
Initial 10
th
 Day 21
th
 Day 
Normal control 154 ± 0.31  174.00 ± 0.8 180.50 ± 0.32 
Diabetic control 181 ± 0.28 165.00 ± 0.64 140.67 ± 0.43 
G. latifolium 
(250 mg/kg) 158 ± 0.17 147.67 ± 2.10  148.33 ± 0.7 
G. latifolium 
(500 mg/kg) 174 ± 0.36 149.00 ± 0.7  144 ± 1.2 
Glibenclamide 
(0.25 mg/kg) 176 ± 0.28 157.00 ± 0.53 167.83 ± 0.9 
N = 6, p < 0.05 
Anti oxidant study 
DPPH antioxidant assay
14 
The free radical scavenging activity of G. latifolium extract was analyzed by, 1, 1-diphenyl-2-
hydrazyl (DPPH) photometric assay. 2 ml of test extract at concentrations ranging from 10 to 
400 µg/ ml was each mixed with 1 ml of 0.5 mM DPPH in methanol.Absorbance at 520 nm was 
taken after 30 min incubation in the dark at room temperature using a spectrophotometer
15
. The 
experiment was done in triplicates and the percentage antioxidant activity was calculated as 
follows: 
 
% of DPPH free radical scavenging= (Absorbance of (control-blank))/(Absorbance of control)  x 
100 
 Where 1 ml methanol  and 2 ml extract were used as blank,  while 1 ml 0.5 m M DPPH solution 
and 2 ml methanol was used as control. Ascorbicacid was used as reference standard 
Table 3: Antioxidant activity of the methanol extract of G. latifolium 
Sample Conc (µg/ml) Absorbance Absorbance 
of control 
Mean % DPPH 
scavenging activity 
Ascorbic acid 10 0.069  
 
 
 
 
     0.812 
86.43 ± 0.17 
100 0.060 90.63± 0.32 
200 0.049 89.49± 0.53 
400 0.038 93.69± 0.82 
Methanol 
extract of  G. 
latifolium 
10 0.269 70.33± 0.38 
100 0.250 76.09± 0.24 
200 0.215 78.18± 0.31 
400 0.190 80.27± 0.78 
 N=3, p<0.05 
 
Figure 1: Percentage antioxidant activity of G. latifolium extract using DPPH photometric  
   assay. 
RESULTS AND DISCUSSION 
 
The anti-hyperglycemic effect of methanol extract of G. latifolium leaves was evaluated for 21 
days.   Alloxan-induced hyperglycemia is due to selective toxicity of alloxan on thepancreatic 
beta cells, generation of superoxide radicals and cytotoxicaction mediated by generation of 
reactive oxygen species. The cytotoxic action of alloxan is mediated by reactive oxygen species, 
with a simultaneous massive increase in cytosolic calcium concentration, leading to a rapid 
destruction of beta cells
16
.  
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 The effect of administration of extracts of G. latifolium on blood glucose level of diabetic rats is 
shown in table 1. Treatment of extract of G. latifolium showed a significant reduction in the 
blood glucose level. 
It also shows that 0.25 mg/kg glibenclamide is lowering glucoselevel significantly compared to 
normal control. Leaf extract at a dose of 500 mg/kg was more effective in reducing the blood 
glucose level than a dose of 250 mg/kg. The variation in blood glucose level in normal and 
experimental rats on 0, 7, 14 and 21 days of treatment has also been recorded.Treatment with G. 
latifolium extract showed signs of recovery as comparable with the standard drug glibenclamide. 
There was significant loss in body weight of diabetic rats compared to normal rats. In diabetics, 
glucose is not available therefore the cells use alternatively proteins for energy; consequently due 
to excessive breakdown of tissue protein a loss in body weight occurs.  Body weight slightly 
increased in the normal control rats compared to initial bodyweight, whereas in diabetic control 
rats there was a significant decrease in body weight. Groups that were treated with glibenclamide  
and  G. latifolium extract (250 and 500 mg/kg) showed significant reduction in bodyweights. The 
final body weights of treated groups were significantly lower than the final weights of normal 
control group. Hence, present study showed a good antidiabetic response of leafextract against 
the experimental animals. 
The antioxidant activity was done in vitro using 1,1-diphenyl-2-hydrazyl (DPPH) 
spectrophotometric assays.  Figure 1 shows the antioxidant activity of G. latifolium and ascorbic 
acid standard. The result showed that G. latifolium extract caused a concentration dependent 
percentage increase of antioxidant activity. DPPH is a stable free radical, it accepts an electron or 
hydrogen   radical   to   become   a   stable   diamagnetic molecule  which  iswidely  used  to  
investigate  radical scavenging  activity. The   degree   of   discoloration   indicates   the radical-
scavenging   potential   of  the   antioxidant.  Result shows that DPPHscavengingwas  increased  
in  a  concentration  dependent manner  compared  to  ascorbic  acid
16
. 
Statistical Analysis 
Graph Pad Prism Version 5.0 for Windows was used for all statistical analyses. Data are 
presented as mean ± SEM  and analyzed by one-way ANOVA followed by Dunnett’s multiple 
comparisontest.  
CONCLUSION 
At present scenario, many researchers are showing their interest in medicinal plants for routine 
scientific investigation of numerous plants extract for biological effects and potential therapeutic 
properties in human. Methanol leaf extract of G. latifolium haveanti-hyperglycemic and anti-
oxidant activities. The methanol extract have antihyperglycemic activity in diabetic rats, most 
likely to be associated with glucose uptake increasing mechanism. Lower doses of the extract 
should be tried in future study to establish the most appropriate dose for clinical trial. G. 
latifolium leabes has shown to be a potential anti-diabetic and thus it can be a promising source 
for anti-diabetic agent.In the present study, the observed DPPH scavenging activity of the 
methanolic extract of G. latifolium might be useful for the development of newer and more 
potent natural antioxidants.  
So, present study concluded that detailed investigation of plants used in local health traditions 
and pharmacological evaluation of these plants and their taxonomical relatives can lead to the 
development of invaluable plant drug for many dreaded diseases includingdiabetes mellitus. 
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